Sep 24 2015
Avantor™ Performance Materials will unveil multiple new products and life sciences capabilities at the CPhI Worldwide 2015 exhibition, October 13-15 in Madrid, Spain.
At its Advance Biopharmaceuticals exhibit, located in booth 7B40, Avantor representatives will share information about the company’s new line of J.T.Baker® High Purity Low Endotoxin sugars, which increase cell culture yield and enhance patient safety, as well as an innovative packaging platform designed to streamline biopharmaceutical manufacturing processes.
High Purity Low Endotoxin Sugars
Avantor has expanded its manufacturing capabilities to purify bioexcipients and is introducing a new platform of J.T.Baker® High Purity Low Endotoxin (HPLE) sugars that increase the efficacy of active pharmaceutical ingredients while improving cell culture yield. Using proprietary purification technology, J.T.Baker® HPLE sugars achieve endotoxin levels that are below regulatory requirements and contain industry leading low impurity levels, reducing the potential for adverse chemical reactions.
Direct Dispense Packaging Platform
The company also is introducing a new J.T.Baker® Direct Dispense packaging platform that delivers pre-weighed salt buffers and cell culture ingredients to help customers streamline biopharmaceutical production. Available for a wide variety of J.T.Baker® dry powder products in quantities ranging from 250g to 15kg, the Direct Dispense packaging platform delivers the exact amount of free-flowing powders and is compatible with near-IR identification testing, reducing the need for sampling, material handling and the risk of cross-contamination.
At its CPhI exhibit, Avantor also will share information on a range of other product offerings, including J.T.Baker® BAKERBOND™ process chromatography media and cGMP-manufactured process salts, sugars and excipients. Visitors to the booth will learn how Avantor’s chemistries, proven quality systems and supply chain security methods can help manufacturers scale up faster and reduce time to market, from discovery to full-scale production.
Avantor representatives also will be accessible to discuss how the company collaborates with customers on manufacturing processes that advance biopharmaceutical production and improve patient safety and welfare.
Exhibitor Showcase Presentation
As part of the CPhI Exhibitor Showcase program, Avantor experts Nandu Deorkar, Ph.D., Vice President of R&D, and William Hesselink, Application Project Manager R&D for Pharmaceuticals, will deliver a presentation on Improving the Robustness of Biopharmaceutical Manufacturing Processes by Controlling Raw Material Variability.
During the presentation, Deorkar and Hesselink will address emerging regulatory requirements in biopharmaceutical manufacturing. They will illustrate critical quality attributes of various raw materials and excipients, along with approaches to control variability and thereby improve biopharmaceutical manufacturing outcomes.
The presentation will take place Tuesday, October 13, at 2:30 p.m. at the CPhI Exhibitor Showcase location: Hall 12, Stand Nr. 12F40.
For more information on how Avantor and J.T.Baker® products and services can help advance biopharmaceuticals, visit www2.avantormaterials.com/CPHINews